MUMBAI: Procter & Gamble Well being, formerly identified as Merck, on Wednesday described a 10.8 per cent jump in June quarter net profit at Rs 48.9 crore.
The profit development arrived even with a fall in sales to Rs 200.3 crore due to the COVID-19 pandemic, as from Rs 224.9 crore in the April-June time period of final 12 months.
“The firm sent a potent double-digit progress for four successive quarters up till the onset of the unparalleled COVID-19 pandemic. Inspite of original influence on account of disruption in organization functions, the enterprise carries on to exhibit a resilient performance,” its Handling Director Milind Thatte reported.
Defending the health and fitness and safety of employees and partners, continuing to provide buyers, and support communities and aid efforts have been the company’s priorities all through the pandemic time, he additional.
In the 18 months to June, the company reported sales of Rs 1,329 crore. The sales figure experienced stood at Rs 818.2 crore in the calendar year 2018, it claimed in a statement.
Profit soon after tax (PAT) for the 18 months period finished June 30, 2020 was Rs 254.1 crore, although the exact stood at Rs 101.7 crore (for continuing operations) in 2018, it extra.
The enterprise described that it has now transitioned from a January-December financial yr to a July-June fiscal, aligned with the fiscal year followed by P&G globally.
Its board has advised a last dividend of Rs 230 for each share, including an a single-time exclusive dividend of Rs 188 per equity share for the monetary calendar year finished June 30, 2020, as per the statement.